Parkinson’s Disease
Parkinson's disease is a progressive neurodegenerative disorder characterized by the gradual degeneration of dopamine-producing neurons in the brain. This loss of dopamine disrupts the normal balance of neurotransmitters, leading to the hallmark symptoms of the disease, which include tremors, stiffness, slowness of movement, and postural instability. As the disease advances, it can also affect cognitive functions and lead to complications such as difficulties with balance and coordination. While the exact cause of Parkinson's disease remains unknown, it is believed to involve a combination of genetic and environmental factors. Treatments primarily focus on managing symptoms and improving quality of life, using medications, physical therapy, and in some cases, surgical interventions. Research continues to explore more effective therapies and potential cures for this challenging condition.
Join Our Clinical Trial
Seeking Participants for Parkinson's Disease Treatment Study
We are excited to announce the launch of a clinical trial for TB006, an innovative treatment for Parkinson's disease, starting in November 2024. This study aims to assess the efficacy and safety of Drug A in managing Parkinson’s disease symptoms and improving quality of life.
If you are interested, please fill out the form below for more information.